Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis

Journal of Surgical Oncology

Volumn 108, Issue 3, 2013, Pages 197-202

  Xu, Xiao Dong ^a,b   He, Xu Jun ^b   Tao, Hou Quan ^b   Zhang, Wei ^b   Wang, Yuan Yu ^b   Ye, Zai Yuan ^a,b   Zhao, Zhong Sheng ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

gastric cancer; miR 301a; prognosis; progression

Indexed keywords

MICRORNA; MICRORNA 301A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL CLONE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION;

GASTRIC CANCER; MIR-301A; PROGNOSIS; PROGRESSION;

ADULT; AGED; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 84881168255     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23374     Document Type: Article

References (21)

1. Bartel DP:, MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Croce CM:, Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
3. Esquela-Kerscher A, Slack FJ:, Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
4. Li Q, Wang G, Shan JL, et al.: MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol 2010; 25: 164-171.
5. Motoyama K, Inoue H, Takatsuno Y, et al.: Over-and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-1075.
6. Tong AW, Fulgham P, Jay C, et al.: MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009; 16: 206-216.
7. Hiyoshi Y, Kamohara H, Karashima R, et al.: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-1922.
8. Ma J, Dong C, Ji C:, MicroRNA and drug resistance. Cancer Gene Ther 2010; 17: 523-531.
9. Ma L, Teruya-Feldstein J, Weinberg RA:, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-689.
10. Nicoloso MS, Spizzo R, Shimizu M, et al.: MicroRNAs-The micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302.
11. Katada T, Ishiguro H, Kuwabara Y, et al.: MicroRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009; 34: 537-542.
12. Guo J, Miao Y, Xiao B, et al.: Differential expression of microRNA species in human gastric cancer versus nontumorous tissues. J Gastroenterol Hepatol 2009; 24: 652-657.
13. Ueda T, Volinia S, Okumura H, et al.: Relation between microRNA expression and progression and prognosis of gastric cancer: A microRNA expression analysis. Lancet Oncol 2010; 11: 136-146.
14. Zhang Z, Li Z, Gao C, et al.: MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-1366.
15. Liu T, Tang H, Lang Y, et al.: MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009; 273: 233-242.
16. Du Y, Xu Y, Ding L, et al.: Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009; 44: 556-561.
17. Zhou P, Jiang W, Wu L, et al.: miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma. Dig Dis Sci 2012; 57: 1171-1180.
18. Chen Z, Chen LY, Dai HY, et al.: miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. 2012; 113: 3229-3235.
19. Shi W, Gerster K, Alajez NM, et al.: MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 2011; 71: 2926-2937.
20. Miko E, Czimmerer Z, Cs-anky E, et al.: Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009; 35: 646-664.
21. Sand M, Skrygan M, Sand D, et al.: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res 2013; 351: 85-98.